Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BioRestorative Therapies, Inc. (BRTX)
USD0.34
+0.01 (+3.03%)
US NASDAQ Healthcare Biotechnology
Address
40 Marcus Drive 11747
Melville, NY, US
Melville, NY, US
CEO
Lance Alstodt
Website
biorestorative.com
IPO
2012-12-05
CIK 1505497 ISIN US0906556065
Description
BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy candidate is BRTX-100. This treatment involves culturing mesenchymal stem cells harvested from a patient's own bone marrow (autologous) to provide a non-surgical solution for painful lumbosacral disc conditions. BRTX-100 has successfully completed Phase 1 clinical trials. The company is also advancing its Metabolic Program, named ThermoStem, which is currently in the preclinical stage. This cell-based therapy targets obesity and other metabolic ailments by employing brown adipose-derived stem cells to generate brown adipose tissue. Beyond these core programs, BioRestorative Therapies also offers an investigational curved needle device designed for delivering cells and various therapeutic materials to the spine and discs. The company fosters strategic research and development partnerships, including agreements with Rohto Pharmaceutical Co., Ltd., Pfizer, Inc., and the University of Pennsylvania. Founded in 1997 and headquartered in Melville, New York, the company was initially known as Stem Cell Assurance, Inc., before rebranding to BioRestorative Therapies, Inc. in August 2011.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.34
+0.01 (+3.03%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
11M
Beta
0.64
Float Shares
5.98M
Free Float %
66.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.82% | -19.13% | -27.60% | -34.74% | -85.12% | -84.24% | -89.12% | -96.47% | -99.35% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
0.34
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-69.70
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-10.3% Q1'26: -7.3% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-36.2% Q1'26: +81.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-3,959.9% Q1'26: -16,434.1% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-4,350.1% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+15.8% Q1'26: +112.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
119.8K
est: 100.0K (+19.8%)
|
145.8K
est: 149.5K (-2.5%)
|
401.0K
est: 855.3K (-53.1%)
|
359.7K
est: 490.0K (-26.6%)
|
1.41M
920.1K – 1.89M
+186.7% YoY
|
2.31M
1.51M – 3.11M
+64.6% YoY
|
3.13M
2.05M – 4.20M
+35.1% YoY
|
118.72M
77.75M – 159.69M
+3,699.0% YoY
|
139.20M
91.16M – 187.23M
+17.2% YoY
|
| EBITDA |
-18.74M
est: -100.0K (-18,643.0%)
|
-14.97M
est: -149.5K (-9,914.5%)
|
-11.37M
est: -855.3K (-1,228.9%)
|
-15.44M
est: -490.0K (-3,050.4%)
|
-1.41M
-1.89M – -920.1K
-186.7% YoY
|
-2.31M
-3.11M – -1.51M
-64.6% YoY
|
-3.13M
-4.20M – -2.05M
-35.1% YoY
|
-118.72M
-159.69M – -77.75M
-3,699.0% YoY
|
-139.20M
-187.23M – -91.16M
-17.2% YoY
|
| EBIT |
-18.86M
est: -100.0K (-18,763.5%)
|
-15.14M
est: -149.5K (-10,025.4%)
|
-11.56M
est: -855.3K (-1,251.0%)
|
-15.65M
est: -490.0K (-3,093.3%)
|
-1.41M
-1.89M – -920.1K
-186.7% YoY
|
-2.31M
-3.11M – -1.51M
-64.6% YoY
|
-3.13M
-4.20M – -2.05M
-35.1% YoY
|
-118.72M
-159.69M – -77.75M
-3,699.0% YoY
|
-139.20M
-187.23M – -91.16M
-17.2% YoY
|
| Net Income |
-13.22M
est: -40.61M (+67.4%)
|
-10.42M
est: -9.92M (-5.0%)
|
-8.98M
est: -12.10M (+25.8%)
|
-14.24M
est: -14.24M (+0.0%)
|
-4.45M
-6.45M – -2.45M
+68.7% YoY
|
-3.64M
-5.28M – -2.01M
+18.2% YoY
|
-3.69M
-4.41M – -2.97M
-1.2% YoY
|
16.14M
8.90M – 23.38M
+537.8% YoY
|
17.27M
9.52M – 25.01M
+7.0% YoY
|
| SGA |
15.58M
est: 16.13M (-3.4%)
|
11.33M
est: 23.85M (-52.5%)
|
6.58M
est: 136.45M (-95.2%)
|
5.89M
est: 78.17M (-92.5%)
|
224.13M
146.78M – 301.48M
+186.7% YoY
|
368.90M
241.59M – 496.20M
+64.6% YoY
|
498.51M
326.48M – 670.54M
+35.1% YoY
|
18.94B
12.40B – 25.47B
+3,699.0% YoY
|
22.21B
14.54B – 29.87B
+17.2% YoY
|
| EPS |
-3.65
est: -5.23 (+30.2%)
|
-2.47
est: -1.10 (-123.9%)
|
-1.16
est: -1.41 (+17.5%)
|
-1.58
est: -1.63 (+3.1%)
|
-0.50
-0.72 – -0.27
+69.6% YoY
|
-0.41
-0.59 – -0.22
+18.2% YoY
|
-0.41
-0.49 – -0.33
-1.2% YoY
|
1.80
0.99 – 2.60
+537.8% YoY
|
1.92
1.06 – 2.78
+7.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-10.97M
OE per share TTM
-1.25
Owner's Yield
-664.33%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
257.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
3
Total invested
37.9K
Insider transactions (90d)
0
Beneficial owners (>5%)
20
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lance Alstodt | 605.67M | 16.80% | 605.67M | — | 605.67M | — | IN | — | 2021-03-19 | ↗ |
| 2 | Francisco Silva | 595.71M | 16.50% | 595.71M | — | 595.71M | — | IN | — | 2021-03-19 | ↗ |
| 3 | Mark Weinreb | 208.98M | 25.70% | 208.98M | — | 132.33M | — | IN | United States | 2013-02-15 | ↗ |
| 4 | Westbury (Bermuda) Ltd. | 55.75M | 8.30% | 55.75M | — | 55.75M | — | CO | Bermuda | 2012-04-27 | ↗ |
| 5 | Westbury Trust | 55.75M | 8.30% | 55.75M | — | 55.75M | — | OO | Bermuda | 2012-04-27 | ↗ |
| 6 | A. Jeffrey Radov | 47.50M | 5.90% | 47.50M | — | 47.50M | — | IN | United States | 2013-02-19 | ↗ |
| 7 | Riverside Partners | 5.71M | 19.90% | 842.9K | 1.88M | 842.9K | 1.88M | PN | United States of America | 2014-08-01 | ↗ |
| 8 | 35-2553872 | 3.05M | 9.90% | 3.05M | — | 3.05M | — | OO | NEVADA | 2019-12-27 | ↗ |
| 9 | SCG Capital, LLC | 1.07M | 9.99% | 1.07M | — | 1.07M | — | OO | Florida | 2018-11-23 | ↗ |
| 10 | John M. Desmarais | 250.0K | 7.70% | 250.0K | — | 250.0K | — | IN | United States | 2015-11-30 | ↗ |
| 11 | NAME OF REPORTING PERSONS | 225.0K | 9.00% | — | 225.0K | — | 225.0K | OO | Cayman Islands | 2021-11-09 | ↗ |
| 12 | Alfred Sollami | 210.0K | 5.80% | — | 210.0K | — | — | HC, IN | Delaware | 2022-07-14 | ↗ |
| 13 | Auctus Fund Management LLC | 210.0K | 5.80% | — | 210.0K | — | — | IA, HC, OO | Delaware | 2022-07-14 | ↗ |
| 14 | Auctus Fund, LLC | 210.0K | 5.80% | — | 210.0K | — | — | PN | Delaware | 2022-07-14 | ↗ |
| 15 | Louis Posner | 210.0K | 5.80% | — | 210.0K | — | — | HC, IN | Delaware | 2022-07-14 | ↗ |
| 16 | Hudson Bay Capital Management LP | 200.0K | 5.42% | — | 200.0K | — | — | PN | State of Delaware | 2022-02-02 | ↗ |
| 17 | Sander Gerber | 200.0K | 5.42% | — | 200.0K | — | — | IN | State of Delaware | 2022-02-02 | ↗ |
| 18 | Altium Capital Management, LP | 200.0K | 4.99% | — | 200.0K | — | — | IA, PN | Delaware, United States of America | 2022-02-14 | ↗ |
| 19 | Altium Growth Fund, LP | 200.0K | 4.99% | — | 200.0K | — | — | PN | Delaware, United States of America | 2022-02-14 | ↗ |
| 20 | Altium Growth GP, LLC | 200.0K | 4.99% | — | 200.0K | — | — | OO | Delaware, United States of America | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
3
-10 vs prev Q
New positions
2
Closed positions
12
Increased
3
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 88.8K +— (+0.0%) | 103.9K -23.1K (-18.2%) | 0.97% -0.042 pp | 0.00% +0.000 pp | USD2.10 -43.8% | 17 qtrs — |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 57.9K +2.6K (+4.7%) | 67.7K -11.3K (-14.4%) | 0.63% +0.002 pp | 0.00% +0.000 pp | USD3.48 -66.1% | 16 qtrs — |
| 3 | DRW SECURITIES, LLC | 46.7K +46.7K (+100.0%) | 54.8K +54.8K (+100.0%) | 0.51% +0.512 pp | 0.00% +0.002 pp | USD1.18 +0.0% | 1 qtrs NEW |
| 4 | WEALTH ALLIANCE | 40.0K +— (+0.0%) | 47.0K -11.0K (-19.0%) | 0.44% -0.019 pp | 0.00% -0.001 pp | USD4.20 -71.9% | 17 qtrs — |
| 5 | STATE STREET CORP | 32.5K +12.0K (+58.7%) | 38.0K +8.7K (+29.8%) | 0.36% +0.122 pp | 0.00% +0.000 pp | USD2.58 -54.3% | 12 qtrs — |
| 6 | CITADEL ADVISORS LLC | 29.2K -77.0K (-72.5%) | 34.2K -117.7K (-77.5%) | 0.32% -0.895 pp | 0.00% +0.000 pp | USD1.45 -18.6% | 2 qtrs — |
| 7 | — | 17.1K +17.1K (+100.0%) | 20.1K +20.1K (+100.0%) | 0.19% +0.188 pp | 0.01% +0.005 pp | USD1.18 +0.0% | 1 qtrs NEW |
| 8 | TWO SIGMA SECURITIES, LLC | 11.8K +11.8K (+100.0%) | 13.8K +13.8K (+100.0%) | 0.13% +0.129 pp | 0.00% +0.002 pp | USD1.18 +0.0% | 1 qtrs NEW |
| 9 | ADVISOR GROUP HOLDINGS, INC. | 2.0K -193.0 (-8.8%) | 2.4K -1.6K (-40.4%) | 0.02% -0.003 pp | 0.00% +0.000 pp | USD1.84 -35.9% | 17 qtrs — |
| 10 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.1K -2.5K (-69.4%) | 1.3K -3.9K (-75.2%) | 0.01% -0.029 pp | 0.00% 0.000 pp | USD1.56 -24.4% | 16 qtrs — |
| 11 | SBI SECURITIES CO., LTD. | 119.00 +14.0 (+13.3%) | 140.00 -12.0 (-7.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.45 -18.6% | 5 qtrs — |
| 12 | BANK OF AMERICA CORP /DE/ | 60.00 +10.0 (+20.0%) | 71.00 -2.0 (-2.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.77 -33.3% | 9 qtrs — |
| 13 | TD WATERHOUSE CANADA INC. | 3.00 +— (+0.0%) | 3.00 -1.0 (-25.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.33 -11.3% | 6 qtrs — |
| 14 | VIRTU FINANCIAL LLC | — -24.4K (-100.0%) | — -35.0K (-100.0%) | 0.00% -0.279 pp | 0.00% -0.002 pp | USD— | 3 qtrs SOLD |
| 15 | CITIGROUP INC | — -1.0 (-100.0%) | — -1.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 16 | WELLS FARGO & COMPANY/MN | — -1.0K (-100.0%) | — -1.5K (-100.0%) | 0.00% -0.011 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 17 | STONEX GROUP INC. | — -37.5K (-100.0%) | — -54.3K (-100.0%) | 0.00% -0.429 pp | 0.00% -0.002 pp | USD— | 17 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
3
Sells
0
Shares acquired
8.3K
Shares disposed
—
Cash buys
3.00
Cash sales
—
Net activity
+8,308
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-06 | Silva Francisco | Director / Officer | A-Award | A | Comon Stock | 11,719 | 1.60 | 18.8K | 171,384 | D | ↗ |
| 2025-10-06 | ALSTODT LANCE | Director / Officer / 10% Owner | A-Award | A | Common Stock | 15,625 | 1.60 | 25.0K | 187,497 | D | ↗ |
| 2025-02-14 | Williams Patrick F. | Director | A-Award | A | Stock Option | 52,632 | 2.46 | 129.5K | 52,632 | D | ↗ |
| 2025-02-14 | Silva Francisco | Director / Officer | A-Award | A | Stock Option | 768,979 | 2.46 | 1.89M | 768,979 | D | ↗ |
| 2025-02-14 | Rosa David A | Director | A-Award | A | Stock Option | 52,632 | 2.46 | 129.5K | 52,632 | D | ↗ |
| 2025-02-14 | Kukekov Nickolay V. | Director | A-Award | A | Stock Option | 52,632 | 2.46 | 129.5K | 52,632 | D | ↗ |
| 2025-02-14 | Kristal Robert Eugene | Officer | A-Award | A | Stock Option | 166,492 | 2.46 | 409.6K | 166,492 | D | ↗ |
| 2025-02-14 | ALSTODT LANCE | Director / Officer | A-Award | A | Stock Option | 791,885 | 2.46 | 1.95M | 791,885 | D | ↗ |
| 2024-10-28 | Broadrick Dale | 10% Owner | S-Sale | D | Common Stock | 1,112 | 1.58 | 1.8K | 445,933 | D | ↗ |
| 2024-04-09 | Silva Francisco | Director / Officer | P-Purchase | A | Common Stock | 6,600 | 1.25 | 8.3K | 155,759 | — | ↗ |
| 2024-04-08 | Silva Francisco | Director / Officer | P-Purchase | A | Common Stock | 1,232 | 1.17 | 1.4K | 149,159 | — | ↗ |
| 2024-03-18 | Silva Francisco | Director / Officer | F-InKind | D | Common Stock | 17,193 | 1.39 | 23.9K | 147,451 | — | ↗ |
| 2024-03-18 | ALSTODT LANCE | Director / Officer | F-InKind | D | Common Stock | 17,633 | 1.39 | 24.5K | 171,872 | — | ↗ |
| 2024-02-13 | Williams Patrick F. | Director | A-Award | A | Stock Option | 79,646 | 1.45 | 115.5K | 79,646 | — | ↗ |
| 2024-02-13 | Silva Francisco | Director / Officer / 10% Owner | A-Award | A | Stock Option | 394,737 | 1.45 | 572.4K | 394,737 | — | ↗ |
| 2024-02-13 | Rosa David A | Director | A-Award | A | Stock Option | 79,646 | 1.45 | 115.5K | 79,646 | — | ↗ |
| 2024-02-13 | Paccasassi Robert | Officer | A-Award | A | Stock Option | 219,298 | 1.45 | 318.0K | 219,298 | — | ↗ |
| 2024-02-13 | Kukekov Nickolay V. | Director | A-Award | A | Stock Option | 79,646 | 1.45 | 115.5K | 79,646 | — | ↗ |
| 2024-02-13 | Kristal Robert Eugene | Officer | A-Award | A | Stock Option | 263,158 | 1.45 | 381.6K | 263,158 | — | ↗ |
| 2024-02-13 | ALSTODT LANCE | Director / Officer / 10% Owner | A-Award | A | Stock Option | 438,596 | 1.45 | 636.0K | 438,596 | — | ↗ |
| 2024-02-09 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 86,041 | 1.32 | 113.6K | 477,972 | — | ↗ |
| 2024-02-08 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 73,959 | 1.25 | 92.4K | 391,931 | — | ↗ |
| 2024-02-07 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 36,374 | 1.38 | 50.2K | 363,419 | — | ↗ |
| 2023-12-01 | Broadrick Dale | 10% Owner | S-Sale | D | Common Stock | 250 | 1.88 | 469.25 | 327,045 | — | ↗ |
| 2023-11-27 | Broadrick Dale | 10% Owner | S-Sale | D | Common Stock | 278 | 1.89 | 525.42 | 327,295 | — | ↗ |
| 2023-09-15 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 10,000 | 1.66 | 16.6K | 327,573 | — | ↗ |
| 2023-09-15 | ALSTODT LANCE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,200 | 1.70 | 3.7K | 189,505 | — | ↗ |
| 2023-09-14 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 10,000 | 1.54 | 15.4K | 317,573 | — | ↗ |
| 2023-09-13 | ALSTODT LANCE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 800 | 1.53 | 1.2K | 188,105 | — | ↗ |
| 2023-09-07 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 1,000 | 1.91 | 1.9K | 317,972 | — | ↗ |
| 2023-09-06 | ALSTODT LANCE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,887 | 1.96 | 5.7K | 187,305 | — | ↗ |
| 2023-08-31 | Silva Francisco | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,954 | 2.22 | 11.0K | 164,644 | — | ↗ |
| 2023-07-28 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 500 | 2.89 | 1.4K | 306,573 | — | ↗ |
| 2023-07-27 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 1,000 | 2.80 | 2.8K | 306,073 | — | ↗ |
| 2023-07-25 | ALSTODT LANCE | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,200 | 2.44 | 10.2K | 184,418 | — | ↗ |
| 2023-03-31 | Silva Francisco | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 747 | 3.56 | 2.7K | 159,690 | — | ↗ |
| 2023-03-20 | Silva Francisco | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 6,729 | 2.92 | 19.6K | 158,943 | — | ↗ |
| 2023-03-20 | ALSTODT LANCE | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 6,729 | 2.92 | 19.6K | 180,218 | — | ↗ |
| 2023-02-22 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 1,000 | 2.95 | 3.0K | 305,073 | — | ↗ |
| 2023-02-18 | Silva Francisco | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 374 | 2.99 | 1.1K | 165,672 | — | ↗ |
| 2023-02-18 | ALSTODT LANCE | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 374 | 2.99 | 1.1K | 186,947 | — | ↗ |
| 2023-02-17 | Williams Patrick F. | Director | A-Award | A | Stock Option | 32,028 | 2.91 | 93.2K | 32,028 | — | ↗ |
| 2023-02-17 | Silva Francisco | Director / Officer / 10% Owner | A-Award | A | Stock Option | 106,762 | 2.91 | 310.7K | 106,762 | — | ↗ |
| 2023-02-17 | Rosa David A | Director | A-Award | A | Stock Option | 32,028 | 2.91 | 93.2K | 32,028 | — | ↗ |
| 2023-02-17 | Paccasassi Robert | Officer | A-Award | A | Stock Option | 88,968 | 2.91 | 258.9K | 88,968 | — | ↗ |
| 2023-02-17 | Kukekov Nickolay V. | Director | A-Award | A | Stock Option | 32,028 | 2.91 | 93.2K | 32,028 | — | ↗ |
| 2023-02-17 | Kristal Robert Eugene | Officer | A-Award | A | Stock Option | 88,968 | 2.91 | 258.9K | 88,968 | — | ↗ |
| 2023-02-17 | ALSTODT LANCE | Director / Officer / 10% Owner | A-Award | A | Stock Option | 106,762 | 2.91 | 310.7K | 106,762 | — | ↗ |
| 2023-02-01 | ALSTODT LANCE | Director / Officer | P-Purchase | A | Common Stock | 400 | 3.10 | 1.2K | 187,321 | — | ↗ |
| 2023-01-27 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 200 | 3.01 | 602.00 | 186,921 | — | ↗ |
| 2023-01-20 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 100 | 3.17 | 317.00 | 186,721 | — | ↗ |
| 2023-01-18 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 100 | 3.09 | 308.70 | 186,521 | — | ↗ |
| 2023-01-09 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 100 | 3.08 | 308.00 | 186,121 | — | ↗ |
| 2022-12-23 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 200 | 3.02 | 604.00 | 185,921 | — | ↗ |
| 2022-12-07 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 1,800 | 2.99 | 5.4K | 185,721 | — | ↗ |
| 2022-11-30 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 100 | 2.77 | 277.00 | 299,073 | — | ↗ |
| 2022-11-21 | Silva Francisco | Officer | P-Purchase | A | Common Stock | 943 | 2.62 | 2.5K | 166,046 | — | ↗ |
| 2022-11-18 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 1,000 | 2.88 | 2.9K | 183,921 | — | ↗ |
| 2022-11-03 | Williams Patrick F. | Director | D-Return | D | Stock Option | 10,490 | 0.00 | — | 0 | — | ↗ |
| 2022-11-03 | Silva Francisco | Officer | D-Return | D | Stock Option | 42,059 | 0.00 | — | 0 | — | ↗ |
| 2022-11-03 | Rosa David A | Director | D-Return | D | Stock Option | 10,490 | 0.00 | — | 0 | — | ↗ |
| 2022-11-03 | Paccasassi Robert | Officer | D-Return | D | Stock Option | 8,277 | 0.00 | — | 0 | — | ↗ |
| 2022-11-03 | Kukekov Nickolay V. | Director | A-Award | A | Stock Option | 25,236 | 0.00 | — | 25,236 | — | ↗ |
| 2022-11-03 | Kristal Robert Eugene | Officer | D-Return | D | Stock Option | 10,490 | 0.00 | — | 0 | — | ↗ |
| 2022-11-03 | ALSTODT LANCE | Officer | D-Return | D | Stock Option | 42,059 | 0.00 | — | 0 | — | ↗ |
| 2022-10-12 | Silva Francisco | Officer | P-Purchase | A | Common Stock | 725 | 3.39 | 2.5K | 165,103 | — | ↗ |
| 2022-10-11 | Silva Francisco | Officer | P-Purchase | A | Common Stock | 806 | 3.69 | 3.0K | 164,378 | — | ↗ |
| 2022-09-23 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 300 | 2.83 | 848.97 | 298,873 | — | ↗ |
| 2022-09-22 | ALSTODT LANCE | Director / Officer | P-Purchase | A | Common Stock | 100 | 2.85 | 285.00 | 182,921 | — | ↗ |
| 2022-08-29 | Silva Francisco | Director / Officer | P-Purchase | A | Common Stock | 2,816 | 3.21 | 9.0K | 163,572 | — | ↗ |
| 2022-08-26 | Silva Francisco | Director / Officer | P-Purchase | A | Common Stock | 2,600 | 3.35 | 8.7K | 160,756 | — | ↗ |
| 2022-07-12 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 900 | 2.97 | 2.7K | 298,373 | — | ↗ |
| 2022-07-12 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 700 | 2.95 | 2.1K | 182,721 | — | ↗ |
| 2022-07-06 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 200 | 3.00 | 600.00 | 298,573 | — | ↗ |
| 2022-06-30 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 1,900 | 3.08 | 5.8K | 297,373 | — | ↗ |
| 2022-06-30 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 1,100 | 3.10 | 3.4K | 182,021 | — | ↗ |
| 2022-06-17 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 600 | 3.80 | 2.3K | 295,373 | — | ↗ |
| 2022-06-16 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 600 | 3.73 | 2.2K | 180,921 | — | ↗ |
| 2022-06-15 | Kristal Robert Eugene | Officer | P-Purchase | A | Common Stock | 194 | 3.61 | 700.34 | 7,994 | — | ↗ |
| 2022-06-15 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 2,000 | 3.81 | 7.6K | 294,773 | — | ↗ |
| 2022-06-15 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 700 | 3.68 | 2.6K | 180,321 | — | ↗ |
| 2022-06-14 | Silva Francisco | Officer | A-Award | A | Common Stock | 263 | 3.78 | 993.46 | 162,114 | — | ↗ |
| 2022-06-14 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 500 | 3.91 | 2.0K | 179,621 | — | ↗ |
| 2022-06-13 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 1,300 | 3.92 | 5.1K | 291,573 | — | ↗ |
| 2022-06-13 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 100 | 3.92 | 392.00 | 179,121 | — | ↗ |
| 2022-06-09 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 600 | 4.23 | 2.5K | 290,273 | — | ↗ |
| 2022-06-08 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 100 | 4.28 | 428.00 | 178,921 | — | ↗ |
| 2022-06-07 | Silva Francisco | Officer | A-Award | A | Common Stock | 565 | 4.65 | 2.6K | 161,851 | — | ↗ |
| 2022-06-07 | Kristal Robert Eugene | Officer | P-Purchase | A | Common Stock | 200 | 4.56 | 912.00 | 7,800 | — | ↗ |
| 2022-06-07 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 3,600 | 4.72 | 17.0K | 286,273 | — | ↗ |
| 2022-06-06 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 3,000 | 4.93 | 14.8K | 282,673 | — | ↗ |
| 2022-06-03 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 1,200 | 4.90 | 5.9K | 279,673 | — | ↗ |
| 2022-06-02 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 1,000 | 4.69 | 4.7K | 278,473 | — | ↗ |
| 2022-06-01 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 9,213 | 4.46 | 41.1K | 277,473 | — | ↗ |
| 2022-06-01 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 200 | 4.60 | 920.00 | 178,821 | — | ↗ |
| 2022-05-27 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 10,957 | 3.61 | 39.6K | 268,260 | — | ↗ |
| 2022-05-26 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 4,950 | 3.51 | 17.4K | 259,303 | — | ↗ |
| 2022-05-26 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 2,700 | 3.52 | 9.5K | 178,621 | — | ↗ |
| 2022-05-02 | ALSTODT LANCE | Director / Officer | P-Purchase | A | Common Stock | 200 | 3.96 | 791.80 | 175,921 | — | ↗ |
| 2022-04-08 | Kristal Robert Eugene | Officer | P-Purchase | A | Common Stock | 7,600 | 5.71 | 43.4K | 7,600 | — | ↗ |
| 2022-04-06 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 2,500 | 5.66 | 14.2K | 254,353 | — | ↗ |
| 2022-04-05 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 30,000 | 5.64 | 169.2K | 251,853 | — | ↗ |
| 2022-03-31 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 10,000 | 4.71 | 47.1K | 316,272 | — | ↗ |
| 2022-03-29 | Broadrick Dale | Director | P-Purchase | A | Common Stock | 700 | 4.84 | 3.4K | 316,972 | — | ↗ |
| 2022-03-21 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 10,000 | 4.35 | 43.5K | 205,853 | — | ↗ |
| 2022-03-18 | Silva Francisco | Officer | A-Award | A | Common Stock | 12,438 | 0.00 | — | 161,286 | — | ↗ |
| 2022-03-18 | ALSTODT LANCE | Officer | A-Award | A | Common Stock | 12,438 | 0.00 | — | 175,521 | — | ↗ |
| 2022-03-09 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 11,875 | 4.00 | 47.5K | 195,853 | — | ↗ |
| 2022-03-08 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 8,125 | 4.00 | 32.5K | 183,978 | — | ↗ |
| 2022-03-07 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 24,392 | 4.43 | 108.1K | 175,853 | — | ↗ |
| 2022-03-04 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 3,800 | 5.51 | 20.9K | 301,272 | — | ↗ |
| 2022-03-03 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 47,648 | 5.47 | 260.6K | 297,472 | — | ↗ |
| 2022-03-02 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 47,840 | 5.61 | 268.4K | 249,824 | — | ↗ |
| 2022-03-01 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 2,270 | 5.55 | 12.6K | 201,984 | — | ↗ |
| 2022-01-24 | ALSTODT LANCE | Director / Officer | P-Purchase | A | Common Stock | 1,470 | 3.40 | 5.0K | 163,083 | — | ↗ |
| 2022-01-05 | ALSTODT LANCE | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 3.85 | 7.7K | 161,613 | — | ↗ |
| 2021-12-01 | ALSTODT LANCE | Director / Officer | P-Purchase | A | Common Stock | 799 | 5.50 | 4.4K | 159,613 | — | ↗ |
| 2021-11-23 | ALSTODT LANCE | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 6.00 | 15.0K | 158,814 | — | ↗ |
| 2021-11-22 | ALSTODT LANCE | Director / Officer | P-Purchase | A | Common Stock | 396 | 6.31 | 2.5K | 156,314 | — | ↗ |
| 2021-11-19 | Silva Francisco | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 6.66 | 26.6K | 11,829 | — | ↗ |
| 2021-11-16 | Silva Francisco | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 6.63 | 26.5K | 7,829 | — | ↗ |
| 2021-11-16 | ALSTODT LANCE | Director / Officer | P-Purchase | A | Common Stock | 1,500 | 6.51 | 9.8K | 155,918 | — | ↗ |
| 2021-11-04 | Williams Patrick F. | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-04 | Silva Francisco | Director / Officer | D-Return | D | Stock Option | 293,479 | 47.60 | 13.97M | 0 | — | ↗ |
| 2021-11-04 | Rosa David A | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-04 | Kukekov Nickolay V. | Director | A-Award | A | Stock Option | 25,236 | 13.50 | 340.7K | 25,236 | — | ↗ |
| 2021-11-04 | Kristal Robert Eugene | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-04 | ALSTODT LANCE | Director / Officer | A-Award | A | Stock Option | 293,479 | 13.50 | 3.96M | 293,479 | — | ↗ |
| 2021-03-18 | Silva Francisco | Director / Officer / 10% Owner | A-Award | A | Stock Option | 1,173,917,974 | 0.01 | 13.97M | 1,173,917,974 | — | ↗ |
| 2021-03-18 | Kukekov Nickolay V. | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-18 | ALSTODT LANCE | Director / Officer / 10% Owner | A-Award | A | Stock Option | 1,173,917,974 | 0.01 | 13.97M | 1,173,917,974 | — | ↗ |
| 2020-11-23 | Silva Francisco | Director / Officer | J-Other | A | Common Stock | 8,375,671 | 0.00 | — | 8,431,629 | — | ↗ |
| 2020-11-23 | ALSTODT LANCE | Director / Officer | J-Other | A | Common Stock | 18,661,666 | 0.00 | — | 18,711,666 | — | ↗ |
| 2020-01-06 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 3,750,000 | 0.01 | 51.0K | 12,549,712 | — | ↗ |
| 2019-12-09 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 81,000 | 0.04 | 2.9K | 1,113,585 | — | ↗ |
| 2019-12-06 | Broadrick Dale | 10% Owner | J-Other | A | Warrant to acquire Common Stock | 555,556 | 0.03 | 16.7K | 555,556 | — | ↗ |
| 2019-12-05 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 20,000 | 0.03 | 560.00 | 22,500 | — | ↗ |
| 2019-12-04 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 92,351 | 0.03 | 2.7K | 8,064,796 | — | ↗ |
| 2019-11-21 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 58,000 | 0.05 | 2.9K | 7,972,445 | — | ↗ |
| 2019-11-15 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 10,000 | 0.07 | 740.00 | 7,834,445 | — | ↗ |
| 2019-10-28 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 1,000 | 0.17 | 170.00 | 7,824,445 | — | ↗ |
| 2019-10-25 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 151,000 | 0.14 | 21.7K | 7,823,445 | — | ↗ |
| 2019-10-23 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 6,500 | 0.14 | 910.00 | 7,672,445 | — | ↗ |
| 2019-10-22 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 36,213 | 0.14 | 5.1K | 7,665,945 | — | ↗ |
| 2019-10-21 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 215,000 | 0.11 | 23.7K | 7,629,732 | — | ↗ |
| 2019-10-17 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 30,000 | 0.12 | 3.6K | 7,414,732 | — | ↗ |
| 2019-10-16 | Broadrick Dale | 10% Owner | P-Purchase | A | Warrant to acquire Common Stock | 3,333,333 | 0.20 | 666.7K | 3,333,333 | — | ↗ |
| 2019-10-15 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 5,000 | 0.14 | 700.00 | 4,050,399 | — | ↗ |
| 2019-10-14 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 13,000 | 0.11 | 1.4K | 4,045,399 | — | ↗ |
| 2019-10-09 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 9,000 | 0.17 | 1.5K | 4,032,399 | — | ↗ |
| 2019-10-08 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 14,000 | 0.14 | 2.0K | 4,023,399 | — | ↗ |
| 2019-09-09 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 2,500 | 0.24 | 600.00 | 35,100 | — | ↗ |
| 2019-09-06 | Weinreb Mark | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 0.23 | 920.00 | 117,000 | — | ↗ |
| 2019-09-05 | Weinreb Mark | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.27 | 2.7K | 105,000 | — | ↗ |
| 2019-09-05 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 100 | 0.25 | 25.49 | 20,100 | — | ↗ |
| 2019-09-04 | Silva Francisco | Officer | P-Purchase | A | Common Stock | 2,500 | 0.24 | 588.75 | 37,503 | — | ↗ |
| 2019-08-30 | Silva Francisco | Officer | P-Purchase | A | Common Stock | 5,000 | 0.28 | 1.4K | 24,503 | — | ↗ |
| 2019-08-29 | Weinreb Mark | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.27 | 675.00 | 95,000 | — | ↗ |
| 2019-08-29 | Tonna Paul Jude | Director | P-Purchase | A | Common Stock | 17,850 | 0.28 | 4.9K | 123,850 | — | ↗ |
| 2019-08-28 | Tonna Paul Jude | Director | P-Purchase | A | Common Stock | 35,000 | 0.27 | 9.5K | 106,000 | — | ↗ |
| 2019-08-28 | Radov A. Jeffrey | Director | P-Purchase | A | Common Stock | 3,000 | 0.28 | 840.00 | 24,500 | — | ↗ |
| 2019-08-27 | Weinreb Mark | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.25 | 625.00 | 87,500 | — | ↗ |
| 2019-08-27 | Tonna Paul Jude | Director | P-Purchase | A | Common Stock | 35,000 | 0.28 | 9.7K | 71,000 | — | ↗ |
| 2019-08-27 | Radov A. Jeffrey | Director | P-Purchase | A | Common Stock | 3,000 | 0.27 | 809.70 | 21,500 | — | ↗ |
| 2019-08-27 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 100 | 0.26 | 26.00 | 10,100 | — | ↗ |
| 2019-08-26 | Silva Francisco | Officer | P-Purchase | A | Common Stock | 3,500 | 0.29 | 1.0K | 12,116 | — | ↗ |
| 2019-08-26 | Radov A. Jeffrey | Director | P-Purchase | A | Common Stock | 3,000 | 0.25 | 750.00 | 18,500 | — | ↗ |
| 2019-08-23 | Radov A. Jeffrey | Director | P-Purchase | A | Common Stock | 3,000 | 0.26 | 789.60 | 15,500 | — | ↗ |
| 2019-08-22 | Weinreb Mark | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.24 | 480.00 | 85,000 | — | ↗ |
| 2019-08-22 | Silva Francisco | Officer | P-Purchase | A | Common Stock | 8,928 | 0.28 | 2.5K | 13,003 | — | ↗ |
| 2019-08-22 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 148,317 | 0.29 | 42.3K | 3,614,529 | — | ↗ |
| 2019-08-21 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 26,700 | 0.26 | 6.9K | 3,466,212 | — | ↗ |
| 2019-08-21 | ALSTODT LANCE | Officer | P-Purchase | A | Common Stock | 100 | 0.23 | 23.00 | 100 | — | ↗ |
| 2019-07-30 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 100 | 0.42 | 42.00 | 3,770,608 | — | ↗ |
| 2019-07-29 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 140,356 | 0.35 | 49.7K | 3,770,508 | — | ↗ |
| 2019-06-13 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 1,000 | 0.42 | 420.00 | 3,619,152 | — | ↗ |
| 2019-06-12 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 25,400 | 0.36 | 9.1K | 3,618,152 | — | ↗ |
| 2019-06-10 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 2,500 | 0.48 | 1.2K | 3,592,752 | — | ↗ |
| 2019-06-06 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 23,000 | 0.43 | 10.0K | 3,590,252 | — | ↗ |
| 2019-06-05 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 200 | 0.42 | 84.00 | 3,567,252 | — | ↗ |
| 2019-06-03 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 5,000 | 0.39 | 2.0K | 3,563,552 | — | ↗ |
| 2019-05-24 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 30,000 | 0.41 | 12.2K | 3,558,552 | — | ↗ |
| 2019-05-23 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 5,000 | 0.54 | 2.7K | 3,528,522 | — | ↗ |
| 2019-05-21 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 82,040 | 0.39 | 32.1K | 3,522,552 | — | ↗ |
| 2019-05-09 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 1,000 | 0.40 | 400.00 | 3,440,512 | — | ↗ |
| 2019-05-07 | Broadrick Dale | 10% Owner | P-Purchase | A | Warrant to acquire Common Stock | 555,555 | 0.70 | 388.9K | 555,555 | — | ↗ |
| 2019-04-25 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 20,100 | 0.65 | 13.1K | 2,328,401 | — | ↗ |
| 2019-04-23 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 11,681 | 0.64 | 7.5K | 2,308,301 | — | ↗ |
| 2019-04-22 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 39,985 | 0.64 | 25.6K | 2,296,620 | — | ↗ |
| 2019-04-18 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 84,474 | 0.63 | 53.2K | 2,256,635 | — | ↗ |
| 2019-04-09 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 100 | 0.85 | 85.00 | 2,172,161 | — | ↗ |
| 2019-04-08 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 200 | 0.91 | 182.00 | 2,172,061 | — | ↗ |
| 2019-04-04 | Broadrick Dale | 10% Owner | P-Purchase | A | Common Stock | 2,500 | 0.80 | 2.0K | 2,500 | — | ↗ |
| 2019-03-25 | Weinreb Mark | Director / Officer | A-Award | A | Stock Option | 208,000 | 0.75 | 156.0K | 208,000 | — | ↗ |
| 2019-03-25 | Tonna Paul Jude | Director | A-Award | A | Stock Option | 125,000 | 0.75 | 93.8K | 125,000 | — | ↗ |
| 2019-03-25 | Silva Francisco | Officer | D-Return | D | Stock Option | 25,000 | 4.70 | 117.5K | 0 | — | ↗ |
| 2019-03-25 | Ryan Charles S. | Director | D-Return | D | Option | 46,000 | 3.73 | 171.6K | 0 | — | ↗ |
| 2019-03-25 | Radov A. Jeffrey | Director | A-Award | A | Stock Option | 5,000 | 0.75 | 3.8K | 5,000 | — | ↗ |
| 2019-03-25 | Paccasassi Robert | Officer | A-Award | A | Stock Option | 50,000 | 0.75 | 37.5K | 50,000 | — | ↗ |
| 2019-03-25 | Desmarais John M | Director / 10% Owner | A-Award | A | Stock Option | 125,000 | 0.75 | 93.8K | 125,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-14.2K
Shares Outstanding
8.99M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Lance Alstodt Chief Executive Officer | 539.6K | 275.0K | — | 500.0K | — | — | 1.31M | 38.03% | ↗ |
| 2 | 2024 | Francisco Silva VP, Research and Development | 514.6K | 262.5K | — | 450.0K | — | — | 1.23M | 36.67% | ↗ |
| 3 | 2024 | Robert Kristal Chief Financial Officer | 293.8K | 90.0K | — | 300.0K | — | — | 683.8K | 43.88% | ↗ |
| 4 | 2023 | Lance Alstodt Chief Executive Officer | 479.2K | 475.0K | — | 300.0K | — | — | 1.25M | 23.92% | ↗ |
| 5 | 2023 | Francisco Silva VP, Research and Development | 454.2K | 450.0K | — | 300.0K | — | — | 1.20M | 24.91% | ↗ |
| 6 | 2023 | Robert Kristal Chief Financial Officer | 240.6K | 127.5K | — | 250.0K | — | — | 618.1K | 40.44% | ↗ |
| 7 | 2022 | Lance Alstodt Chief Executive Officer | 400.0K | — | 52.4K | — | — | — | 452.4K | 11.58% | ↗ |
| 8 | 2022 | Francisco Silva VP, Research and Development | 375.0K | — | 52.4K | — | — | — | 427.4K | 12.25% | ↗ |
| 9 | 2022 | Robert Kristal Chief Financial Officer | 175.0K | — | — | — | — | — | 175.0K | 0.00% | ↗ |
| 10 | 2021 | Lance Alstodt Chief Executive Officer | 275.0K | — | 6.98M | 14.08M | — | — | 21.34M | 98.71% | ↗ |
| 11 | 2021 | Francisco Silva VP, Research and Development | 259.4K | — | 6.98M | 14.08M | — | — | 21.33M | 98.78% | ↗ |
| 12 | 2021 | Robert Kristal Chief Financial Officer | 29.2K | — | — | 53.2K | — | — | 82.4K | 64.60% | ↗ |
| 13 | 2020 | Francisco Silva VP, Research and Development | 207.6K | — | — | — | — | — | 207.6K | 0.00% | ↗ |
| 14 | 2020 | Mark Weinreb Chief Executive Officer | 179.2K | — | — | — | — | — | 179.2K | 0.00% | ↗ |
| 15 | 2020 | Lance Alstodt Chief Executive Officer | 64.3K | — | — | — | — | — | 64.3K | 0.00% | ↗ |
| 16 | 2019 | Mark Weinreb Chief Executive Officer | 370.0K | — | — | — | — | 2.4K | 372.4K | 0.00% | ↗ |
| 17 | 2019 | Lance Alstodt Chief Executive Officer | 350.0K | — | — | — | — | — | 350.0K | 0.00% | ↗ |
| 18 | 2019 | Francisco Silva VP, Research and Development | 287.5K | — | — | — | — | — | 287.5K | 0.00% | ↗ |
| 19 | 2018 | Adam Bergstein Senior VP, Planning and Business Development | 264.5K | — | — | 1.49M | — | — | 1.76M | 84.93% | ↗ |
| 20 | 2018 | Mark Weinreb, Chief Executive Officer | 400.0K | — | — | 291.8K | — | 7.2K | 699.0K | 41.75% | ↗ |
| 21 | 2018 | Francisco Silva, VP, Research and Development | 287.5K | 23.0K | — | 107.8K | — | — | 418.3K | 25.77% | ↗ |
| 22 | 2018 | Robert Paccasassi, VP, Quality and Compliance | 201.3K | 32.7K | — | 53.9K | — | — | 287.9K | 18.72% | ↗ |
| 23 | 2017 | Mark Weinreb, Chief Executive Officer | 400.0K | 32.0K | — | 784.7K | — | 7.2K | 1.22M | 64.11% | ↗ |
| 24 | 2017 | Francisco Silva, VP, Research and Development | 250.0K | 6.0K | — | 200.4K | — | — | 456.4K | 43.91% | ↗ |
| 25 | 2017 | Francisco Silva, VP of Research and Development | 250.0K | 6.0K | — | 200.4K | — | — | 456.4K | 43.91% | ↗ |
| 26 | 2017 | Mandy Clyde, VP of Operations | 130.0K | — | — | 135.1K | — | — | 265.1K | 50.96% | ↗ |
| 27 | 2017 | Edward Field President of Disc/Spine Division | 175.0K | 18.0K | — | — | — | — | 193.0K | 0.00% | ↗ |
| 28 | 2017 | Adam Bergstein Senior VP, Planning and Business Development | — | — | — | — | — | — | — | — | ↗ |
| 29 | 2017 | Robert Paccasassi, VP, Quality and Compliance | — | — | — | — | — | — | — | — | ↗ |
| 30 | 2016 | Mark Weinreb, Chief Executive Officer | 400.0K | 96.0K | — | 887.0K | — | 7.2K | 1.39M | 63.80% | ↗ |
| 31 | 2016 | Edward Field President of Disc/Spine Division | 300.0K | 36.0K | — | 263.0K | — | — | 599.0K | 43.91% | ↗ |
| 32 | 2016 | Francisco Silva, VP of Research and Development | 250.0K | 26.0K | — | 197.2K | — | — | 473.2K | 41.67% | ↗ |
| 33 | 2016 | Mandy Clyde, VP of Operations | — | — | — | — | — | — | — | — | ↗ |
| 34 | 2015 | Mark Weinreb, Chief Executive Officer | 400.0K | 200.0K | — | 743.3K | — | 7.2K | 1.35M | 55.04% | ↗ |
| 35 | 2015 | Edward Field President of Disc/Spine Division | 252.5K | 7.6K | — | 291.9K | — | — | 552.0K | 52.88% | ↗ |
| 36 | 2015 | Edward L. Field President, Disc/Spine Division | 252.5K | 7.6K | — | 291.9K | — | — | 552.0K | 52.88% | ↗ |
| 37 | 2015 | Francisco Silva, VP of Research and Development | 250.0K | — | — | 91.5K | — | — | 341.5K | 26.79% | ↗ |
| 38 | 2015 | Francisco Silva VP of Research and Development | 250.0K | — | — | 91.5K | — | — | 341.5K | 26.79% | ↗ |
| 39 | 2014 | Mark Weinreb, Chief Executive Officer | 450.0K | 225.0K | — | 1.10M | — | 34.4K | 1.81M | 60.73% | ↗ |
| 40 | 2014 | Francisco Silva VP of Research and Development | 230.0K | 25.0K | — | 283.6K | — | — | 538.6K | 52.65% | ↗ |
| 41 | 2014 | Francisco Silva, VP of Research and Development | — | — | — | 283.6K | — | — | — | — | ↗ |
| 42 | 2014 | Edward L. Field President, Disc/Spine Division | — | — | — | — | — | — | — | — | ↗ |
| 43 | 2014 | Mandy Clyde, VP of Operations | — | — | — | 86.8K | — | — | — | — | ↗ |
| 44 | 2013 | Mark Weinreb, Chief Executive Officer | 240.0K | 300.0K | — | 50.6K | — | 25.0K | 565.0K | 8.95% | ↗ |
| 45 | 2013 | Mandy Clyde, VP of Operations | — | — | — | 16.2K | — | — | — | — | ↗ |
| 46 | 2013 | Francisco Silva, VP of Research and Development | — | — | — | 20.2K | — | — | — | — | ↗ |
| 47 | 2012 | Mark Weinreb, Chief Executive Officer | 509.0K | 324.5K | — | 696.0K | — | 231.6K | 1.76M | 39.52% | ↗ |
| 48 | 2012 | Francisco Silva, Vice President of Research | 179.2K | — | — | 115.3K | — | — | 294.4K | 39.15% | ↗ |
| 49 | 2012 | Mandy Clyde, Vice President of Operations | 100.0K | — | — | 50.0K | — | — | 150.0K | 33.31% | ↗ |
| 50 | 2012 | Francisco Silva, VP of Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 51 | 2012 | Mark Weinreb, Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 52 | 2012 | Mandy Clyde, VP of Operations | — | — | — | — | — | — | — | — | ↗ |
| 53 | 2011 | Mark Weinreb, Chief Executive Officer | 390.0K | 195.0K | 123.9K | — | — | 88.0K | 796.9K | 15.55% | ↗ |
| 54 | 2011 | Mark Weinreb, Chief Executive Officer | 390.0K | 195.0K | 123.9K | — | — | 88.0K | 796.9K | 15.55% | ↗ |
| 55 | 2011 | Francisco Silva, Vice President of Research and Development | 110.8K | 30.0K | — | 41.6K | — | — | 182.4K | 22.81% | ↗ |
| 56 | 2011 | Francisco Silva, Vice President of Research | 110.8K | 30.0K | — | 41.6K | — | — | 182.4K | 22.81% | ↗ |
| 57 | 2010 | Mark Weinreb, Chief Executive Officer | 90.0K | 45.0K | — | 437.2K | — | — | 572.2K | 76.41% | ↗ |
| 58 | 2010 | Gloria McConnell, President | 26.7K | — | 103.9K | — | — | 120.0K | 250.6K | 41.46% | ↗ |
| 59 | 2010 | Francisco Silva, Vice President of Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 60 | 2009 | Mark Weinreb, Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 61 | 2009 | Gloria McConnell, President | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Lance Alstodt | Chairman of the Board, President & Chief Executive Officer | 596.7K | male |
| Francisco J. Silva | Vice President of Research & Development, Secretary and Director | 566.7K | male |
| Robert Eugene Kristal | Chief Financial Officer | 343.8K | male |
| Crystal Romano | Head of Global Commercial Operations | — | female |
| Stephen Kilmer | Investor Relations Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BRTX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
